Rezultatele cercetarii clinice: studiul proprietăţilor citoprotectoare (chimio, radioprotectoare) a emulsiei orale Flamena 100 ml la pacientele cu cancer mamar şi cancerul organelor reproductive supuse chimiosau radioterapiei

Abstract

Summary: It is studied the Flamen indigenous combined medical substance 100 ml oral emulsion containing the active ingredients glycine and dihidroquercitina. In General Oncology Clinic and the IP Mammology Medical University “Nicolae Testemitanu” clinical trial was conducted according to the principles of good practice in research involving breast cancer and cancer of the reproductive organs. It was determined that 100ml of Flamen is harmless, easy to administer and is recommended for those suffering from malignancies as adjuvant radiotherapy after polichymioterapy. It is considered to have antyoxydant effects, liver, immune stimulator and detoxifier.